Dr. Joseph Antin, MD
Claim this profileDana-Farber Cancer Institute (adult patients)
Studies Aplastic Anemia
Studies Post-Implantation Syndrome
2 reported clinical trials
6 drugs studied
Affiliated Hospitals
More about Joseph Antin, MD
Clinical Trial Related3 years of experience running clinical trials · Led 2 trials as a Principal Investigator · 0 Active Clinical TrialsTreatments Joseph Antin, MD has experience with
- Alemtuzumab
- Cyclosporins
- Fludarabine
- Mycophenolate Mofetil
- Tacrolimus
- Autologous CD34+ HSC Cells Transduced With The Lentiviral Vector Containing A ShRNA Targeting BCL11a
Breakdown of trials Joseph Antin, MD has run
Aplastic Anemia
Post-Implantation Syndrome
Dyskeratosis Congenita
Bone Marrow Failure
Dyskeratosis congenita
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
What does Joseph Antin, MD specialize in?
Is Joseph Antin, MD currently recruiting for clinical trials?
Are there any treatments that Joseph Antin, MD has studied deeply?
What is the best way to schedule an appointment with Joseph Antin, MD?
What is the office address of Joseph Antin, MD?
Is there any support for travel costs?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.